Caravelle International Group Announces a Private Placement of up to $6.8 Million
SINGAPORE, Jan. 10, 2024 /PRNewswire/ — Caravelle International Group (the “Company”, Nasdaq: CACO), a trailblazing global ocean technology company, today announced that it has entered into a securities purchase agreement with two institutional investors (the “Investors”
Kia Signs MoU to Offer Ride Hailing PBVs to Drivers on the Uber Platform
MoU formalizes collaboration between Kia and Uber, as Kia plans to develop and offer PBVs for driversKia’s specialized PBVs will offer innovative mobility improvements, supporting Uber in achieving its 2040 zero-emission goal PBVs offer enhanced versatility, and increased possibilities for bus
Throat Pastilles And Cough Drops Market size to grow by USD 1.25 billion from 2023-2028: Market Growth, Size, Research Report and Forecast (2024-2028)- Technavio
NEW YORK, Jan. 10, 2024 /PRNewswire/ — The throat pastilles and cough drops market size is expected to grow by USD 1.25 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 3.72% during the forecast period, according to Technavio Research. Company P
Global Switchgear Market Forecast Report to 2028: Outdoor Segment, By Installation, to be Fastest Growing Market from 2023 to 2028
DUBLIN, Jan. 10, 2024 /PRNewswire/ — The “Switchgear Market by Insulation (Gas-insulated, Air-insulated), Installation (Indoor, Outdoor), Current (AC, DC), Voltage (Low (up to 1 kV), Medium (2-36 kV), High (Above 36 kV), End User and Region – Global Forecast to 2028” report
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies – ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
The disease awareness and the emergence of new products in the pipeline will add to the focal segmental glomerulosclerosis market growth in the future. In addition, persistently rising cases of FSGS in the forecast period will contribute to the rise in the focal segmental glomerulosclerosis treatmen
Clorox Announces Feb. 1 Webcast of Second-Quarter Fiscal Year 2024 Results
OAKLAND, Calif., Jan. 10, 2024 /PRNewswire/ — The Clorox Company (NYSE: CLX) will issue its second-quarter fiscal year 2024 results on Feb. 1, 2024. Timing for the announcement will be as follows: 1:15 p.m. PT / 4:15 p.m. ET: Press release and prepared management remarks posted on the company&
BlackBerry to Participate in Upcoming Investor Event
BlackBerry CEO to speak at the upcoming Needham Growth Conference WATERLOO, ON, Jan. 10, 2024 /PRNewswire/ — BlackBerry Limited (NYSE: BB; TSX: BB) today announced its participation at the following investor conference: 26th Annual Needham Growth Conference – Wednesday, January 17, 2024, at
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth Liquid biopsy and HRD on SOPHiA DDM™ Platform continue to grow year-over-year, with Tennessee Oncology, Dasa and The Royal Marsden announced today BOSTON and ROLLE, Switzerland, Jan. 10, 2024 /PRNewswire/ 
Assistiv Labs Launches End-to-End Accessibility Testing Service to Ensure Digital Products Are Accessible to All
PORTLAND, Ore., Jan. 10, 2024 /PRNewswire/ — Assistiv Labs, a leading provider of accessibility testing solutions, today announced the launch of its new end-to-end accessibility testing service. The service provides a comprehensive and reliable way to ensure that digital products are accessib
Liquid Filled Hard Capsules Market size to grow by USD 1.08 billion from 2023 to 2028, with a steady 7.68% CAGR- Technavio
NEW YORK, Jan. 10, 2024 /PRNewswire/ — The liquid filled hard capsules market is expected to grow by USD 1.08 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 7.68% during the forecast period, according to Technavio Research. The market has be
